Salivary immunoglobulin A and lysozyme in patients with psoriasis

Annals of the Academy of Medicine Singapore

Volumn 33, Issue 3, 2004, Pages 307-310

  Koh, David ^a,c   Yang, Y ^a   Khoo, L ^b   Nyunt, S Z ^a   Ng, V ^a   Goh, C L ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL SKIN CENTRE   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Psoriasis; Salivary IgA; Salivary lysozyme

Indexed keywords

BIOLOGICAL MARKER; IMMUNOGLOBULIN A; LYSOZYME;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; HUMAN; IMMUNOGLOBULIN PRODUCTION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; MAJOR CLINICAL STUDY; MALE; MUCOSAL IMMUNITY; PSORIASIS; SALIVA LEVEL; SINGAPORE; SMOKING;

EID: 3142735948     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Whyte HJ, Baughman RD. Acute guttate psoriasis and streptococcal infection. Arch Dermatol 1964;89:350-6.
2. Bartenjev I, Rogl Butina M, Potocnik M. Subclinical microbial infection in patients with chronic plaque psoriasis. Acta Derm Venereol Suppl (Stockh) 2000;211:17-8.
3. Mestecky J. Saliva as a manifestation of the common mucosal immune system. Ann N Y Acad Sci 1993;694:184-94.
4. Gleeson M, Cripps AW, Clancy RL. Modifiers of the human mucosal immune system. Immunol Cell Biol 1995;73:397-404.
5. Klentrou P, Cieslak T, MacNeil M, Vintinner A, Plyley M. Effect of moderate exercise on salivary immunoglobulin A and infection risk in humans. Eur J Appl Physiol 2002;87:153-8.
6. Gordon LI, Douglas SD, Kay NE, Yamada O, Osserman EF, Jacob HS. Modulation of neutrophil function by lysozyme. Potential negative feedback system of inflammation. J Clin Invest 1979;64:226-32.
7. Osserman EF, Klockars M, Halper J, Fischel RE. Effects of lysozyme on normal and transformed mammalian cells. Nature 1973;243:331-5.
8. Moutsopoulos HM, Karsh J, Wolf RO, Tarpley TM, Tylenda A, Papadopoulous NM. Lysozyme determination in parotid saliva from patients with Sjogren's syndrome. Am J Med 1980;69:39-42.
9. Jolles P, Jolles J. What is new in lysozyme research? Always a model system, today as yesterday. Mol Cell Biochem 1984;63:165-89.
10. Fredriksson T, Pettersson U. Severe psoriasis - oral therapy with a new retinoid. Dermatologica 1978;157:238-44.
11. th ed. Philadelphia: WB Saunders, 1991:711.
12. Yang Y, Koh D, Ng V, Lee CY, Chan G, Dong F, et al. Self-perceived work-related stress and the relationship with salivary IgA and Isozyme among emergency department nurses. Occup Environ Med 2002;59:836-41.
13. Kugler J, Hess M, Haake D. Secretion of salivary immunoglobulin A in relation to age, saliva flow, mood state, secretion of albumin, cortisol, and catecholamines in saliva. J Clin Immunol 1992;12:45-9.
14. Gasior-Chrzan B, Falk ES. Lysozyme and IgA concentrations in serum and saliva from psoriatic patients. Acta Derm Venereol 1992;72:138-40.
15. del Castillo Carrillo LF, Schwarz W, Hornstein OP. Immunoglobulins in serum, whole saliva, and parotid saliva of male healthy and psoriatic individuals. Arch Dermatol Res 1981;271:63-71.
16. Oon CH, Goodwin PG, Kind PR, Seah PP, Fry L. Salivary IgA in patients with psoriasis and dermatitis herpetiformis. Acta Derm Venereol 1973;53:340-2.
17. Guilhou JJ, Clot J, Meynadier J, Lapinski H. Immunological aspects of psoriasis. I. Immunoglobulins and anti-IgG factors. Br J Dermatol 1976;94:501-7.
18. Syrjanen SM. Chemical analysis of parotid saliva and lacrimal fluid in psoriatics. Arch Dermatol Res 1983;275:152-5.
19. Weigl BA. Immunoregulatory mechanisms and stress hormones in psoriasis (part 1). Int J Dermatol 1998;37:350-7.